Clinical Trials List
Protocol NumberA011-13 (HYPERION) MK-7962-005
Completed
2021-11-01 - 2025-03-12
Phase III
Terminated3
ICD-10I27.0
Primary pulmonary hypertension
ICD-9416.0
Primary pulmonary hypertension
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 戴以信 Division of Emergency Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Po-Sheng Chen Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
7 participants
-
Global
662 participants
